Literature DB >> 32379308

Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection.

Lucia Fernandez Gasso1, Nicolas M Maneiro Melon2, Fernando Sarnago Cebada2, Jorge Solis1,3, Julio Garcia Tejada2.   

Abstract

Entities:  

Year:  2020        PMID: 32379308      PMCID: PMC7239194          DOI: 10.1093/eurheartj/ehaa400

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
A 39-year-old-man presented to the Emergency Department after 5 days of fever, cough, myalgia, oppressive chest pain, and dyspnoea at rest. He had no cardiovascular risk factors or relevant past medical history. On admission, he had a temperature of 38.9°C, blood pressure of 127/71 mmHg, heart rate of 112 b.p.m., and oxygen saturation of 89%. Physical exam revealed decreased breath sounds at the base of the lungs. Chest X-ray showed multifocal bilateral patchy airspace opacities consistent with bilateral viral pneumonia (Panel A). Nasopharyngeal and oropharyngeal swabs confirmed SARS-CoV-2. In-hospital ECG showed normal ST-segment and repolarization (Panel B). Laboratory analysis revealed: ferritin 967 μg/L (normal 30–400), C-reactive-protein 26 mg/dL (0.10–0.50 mg/dL), D-dimer 322 ng/mL (<500), lymphocyte count 800/μL, lactate dehydrogenase (LDH) 297 U (135–225), and normal troponin. He was started with hydroxychloroquine, azithromycin, lopinavir/ritonavir, and tocilizumab. Over the course of the next 2 days, his respiratory status rapidly deteriorated, requiring intubation for hypoxaemic respiratory failure and mechanical life support. After 8 days, the patients was extubated and progressively improved. In a routine blood test 13 days after admission, a high creatinine kinase of 573 U/L (34–171) and high sensitivity troponin T of 2204 ng/L (normal <14) was seen. ECG (Panel C) showed mild ST-elevation in leads II, III, aVF, and V4–V6; appearance of a dominant R wave in V1–V4; and Q wave in leads II, III, aVF, and V5–V6. A point-of-care ultrasound showed mild left ventricular systolic dysfunction (LVEF: 50–55%); severe basal and middle inferoseptal, inferolateral, and inferior wall hypokinesis; and basal inferior and lateral hypokinesis of the right ventricle. Although the patient was asymptomatic, a coronary angiogram was performed. It did not reveal any atherosclerotic lesions; however, it did show a large and severe lumen narrowing in the first obtuse marginal branch artery bordered by normal segments compatible with type 2A in the Saw classification of spontaneous coronary artery disease (SCAD) (Panel D, arrow); moderate lumen narrowing in the distal left anterior descending artery that extended to the end of the artery compatible with type 2B SCAD (Panel E, arrow); and a mild fistula between the proximal segment of the right coronary and the pulmonary artery (Panel F, arrow) (Supplementary material online, ). Regarding the typical type 2 SCAD appearance, no intravascular imaging was performed because of the potential risks of extending the dissection with coronary wires or contrast injections. Following current recommendations, as the patient was stable with normal coronary flow in the affected vessels, a conservative therapy was decided on. Autoimmune and rheumatological disease was ruled out. The final diagnosis was myocardial infarction due to multivessel acute SCAD associated with severe acute respiratory syndrome SARS-CoV-2. SCAD has been described in case reports of patients with various systemic inflammatory diseases but has been rarely described in relation to SARS-CoV-2 infection. Recently, it has been suggested that the pathogenesis of SARS-CoV-2 is mediated by disproportional immune responses and the ability of the virus to circumvent innate immunity that induces a proinflammatory cytokine generation. This could be the predisposing factor in the development of SCAD. Although the use and duration of antiplatelet therapies in SCAD are controversial, because of the myocardial infarction and the hypercoagulable state related to the infection, a longer dual antiplatelet therapy with aspirin and an ADP receptor antagonist was decided on. Supplementary material is available at European Heart Journal online. Click here for additional data file.
  8 in total

1.  COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection?

Authors:  Fahimehalsadat Shojaei; Zahra Habibi; Sogand Goudarzi; Fatemeh Dehghani Firouzabadi; Sahar Memar Montazerin; Homa Najafi; Farima Kahe; Kaveh Momenzadeh; Mahshid Mir; Faris Khan; Umer Jamil; Adeel Jamil; Jane J Lee; Gerald Chi
Journal:  Med Hypotheses       Date:  2020-11-22       Impact factor: 1.538

Review 2.  COVID-19 and sudden cardiac death: A new potential risk.

Authors:  Rakesh Yadav; Ragav Bansal; Sudhanshu Budakoty; Parag Barwad
Journal:  Indian Heart J       Date:  2020-10-17

3.  Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient.

Authors:  Silvia Romiti; Marco Totaro; Amalia Laderchi; Mariangela Peruzzi; Mattia Vinciguerra; Ernesto Greco
Journal:  Front Cardiovasc Med       Date:  2021-01-11

Review 4.  Aortic Pathology During COVID - 19 Pandemics. Clinical Reports in Literature and Open Questions on the two Co-Occurring Conditions.

Authors:  Valeria Silvestri; Gregorio Egidio Recchia
Journal:  Ann Vasc Surg       Date:  2021-04-03       Impact factor: 1.466

5.  Multivessel spontaneous coronary artery dissection in a patient after mild COVID-19: A case report.

Authors:  Konstantin Kireev; Vadim Genkel; Alla Kuznetsova; Rifat Sadykov
Journal:  SAGE Open Med Case Rep       Date:  2020-11-27

6.  Spontaneous coronary artery dissection in a patient with recent COVID-19 infection: A case report.

Authors:  Mohammad Javad Alemzadeh-Ansari; Amir Akbar Fakhrabadi; Ahmad Amin; Farnaz Rafiee; Golnaz Houshmand
Journal:  Clin Case Rep       Date:  2022-10-03

7.  Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report.

Authors:  Jonathan Solaimanzadeh; Aaron Freilich; Michael R Sood
Journal:  J Med Case Rep       Date:  2021-05-28

8.  Cardiac manifestations in COVID-19 patients-A systematic review.

Authors:  Ahmed M A Shafi; Safwan A Shaikh; Manasi M Shirke; Sashini Iddawela; Amer Harky
Journal:  J Card Surg       Date:  2020-07-11       Impact factor: 1.620

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.